6C46.22ICD-11 MMS 2026-01
Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained partial remission
Description
After a diagnosis of Stimulant dependence including amphetamines, methamphetamine and methcathinone but excluding caffeine, cocaine and synthetic cathinones, and often following a treatment episode or other intervention (including self-help intervention), there is a significant reduction in amphetamine or other stimulant consumption for more than 12 months, such that even though amphetamine or other stimulant use has occurred during this period, the definitional requirements for dependence have not been met.
Index terms
- Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained partial remission
Excludes
Exclusions from above levels
Sibling codes
6C46.20– Stimulant dependence including amphetamines, methamphetamine or methcathinone, current use6C46.21– Stimulant dependence including amphetamines, methamphetamine or methcathinone, early full remission6C46.23– Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained full remission6C46.2Z– Stimulant dependence including amphetamines, methamphetamine or methcathinone, unspecified
Foundation entity
Stimulant dependence including amphetamines, methamphetamine or methcathinone, sustained partial remission – http://id.who.int/icd/entity/671215150
Allowed postcoordination axes
Part of: 6C46.2: Stimulant dependence including amphetamines, methamphetamine or methcathinone › 6C46: Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone › 06: Mental, behavioural or neurodevelopmental disorders